Retraction Note: Cancer Chemotherapy and Pharmacology (2022) 89:761-772 https://doi.org/10.1007/s00280-022-04428-0
The Authors have retracted this article. After publication the authors found a flaw in the way the raw data was handled for this study and found that the data analysis was incomplete. The authors re-analysed the data and found that the conclusions initially drawn from the results were no longer supported. The authors, therefore, no longer have confidence in the results presented in this article. All authors agree to this retraction.
Anzeige
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.